Medicines Healthcare Products Regulatory Agency
class="gem-c-govspeak govuk-govspeak gem-c-govspeak--direction-ltr govuk-!-margin-bottom-0">
The MHRAs Data Strategy sets out an ambition to promote data-driven innovation and early access to innovative products through Real-World Evidence (RWE) and proactive approaches to safety surveillance. In support of this, the MHRA is launching a pilot RWE Scientific Dialogue Programme during 2025. This initiative is designed to help innovators refine their evidence generation strategies while providing clear guidance on regulatory expectations.